1. Home
  2. PRTH vs ALT Comparison

PRTH vs ALT Comparison

Compare PRTH & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTH
  • ALT
  • Stock Information
  • Founded
  • PRTH 2005
  • ALT 1997
  • Country
  • PRTH United States
  • ALT United States
  • Employees
  • PRTH N/A
  • ALT N/A
  • Industry
  • PRTH EDP Services
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRTH Technology
  • ALT Health Care
  • Exchange
  • PRTH Nasdaq
  • ALT Nasdaq
  • Market Cap
  • PRTH 526.3M
  • ALT 457.0M
  • IPO Year
  • PRTH N/A
  • ALT N/A
  • Fundamental
  • Price
  • PRTH $6.63
  • ALT $7.49
  • Analyst Decision
  • PRTH Buy
  • ALT Buy
  • Analyst Count
  • PRTH 2
  • ALT 6
  • Target Price
  • PRTH $9.00
  • ALT $18.80
  • AVG Volume (30 Days)
  • PRTH 58.8K
  • ALT 1.9M
  • Earning Date
  • PRTH 11-07-2024
  • ALT 11-12-2024
  • Dividend Yield
  • PRTH N/A
  • ALT N/A
  • EPS Growth
  • PRTH N/A
  • ALT N/A
  • EPS
  • PRTH N/A
  • ALT N/A
  • Revenue
  • PRTH $851,914,000.00
  • ALT $409,000.00
  • Revenue This Year
  • PRTH $18.70
  • ALT N/A
  • Revenue Next Year
  • PRTH $11.40
  • ALT N/A
  • P/E Ratio
  • PRTH N/A
  • ALT N/A
  • Revenue Growth
  • PRTH 14.42
  • ALT N/A
  • 52 Week Low
  • PRTH $2.79
  • ALT $2.32
  • 52 Week High
  • PRTH $7.80
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • PRTH 61.32
  • ALT 66.27
  • Support Level
  • PRTH $5.01
  • ALT $6.45
  • Resistance Level
  • PRTH $5.78
  • ALT $7.20
  • Average True Range (ATR)
  • PRTH 0.38
  • ALT 0.40
  • MACD
  • PRTH 0.10
  • ALT 0.08
  • Stochastic Oscillator
  • PRTH 58.12
  • ALT 80.00

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium businesses enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments and Enterprise Payments. SMB Payments segment which generates majority revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging priority's proprietary software platform, distributed through ISO; B2B Payments segment provides AP automation solutions to corporations, software partners and industry FIs: and Enterprise Payments segment provides embedded payment and treasury solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: